Shavano Park, Texas Clinical Trials

A listing of Shavano Park, Texas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

adenocarcinoma of prostate
orchiectomy
androgens
hormone therapy
antiandrogen therapy
South Texas Accelerated Research Therapeutics
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
A Study of SGN-B6A in Advanced Solid Tumors

This trial will look at a drug called SGN-B6A to find out whether it is safe for people who have solid tumors. It will study SGN-B6A to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether …

cancer, ovarian
cancer of the ovary
small cell lung cancer
cervical cancer
ovarian cancer
South Texas Accelerated Research Therapeutics
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Study of ATI-2138 in Adult Participants with Moderate to Severe Atopic Dermatitis

This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.

Aclaris Investigational Site
 (6.2 away) Contact site
  • 0 views
  • 23 Jan, 2025
  • +4 other locations
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b

Phase 1b, a study in high grade serous ovarian cancer and nonsmall cell lung cancer to evaluate the safety and clinical activity of the antibody-drug conjugate (ADC) XMT-1592.

alopecia
measurable disease
hair thinning
metastasis
ovarian cancer
NEXT Oncology
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
NBE-002 in Patients With Advanced Solid Tumors

This first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of NBE-002, a novel anti-ROR1 antibody-drug conjugate, in patients with advanced solid tumors.

advanced malignant solid tumor
solid neoplasm
solid tumor
sarcoma
advanced solid tumor
NEXT Oncology
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

fatty liver
fibroscan
hepatic fibrosis
fibrosis
vcte
Pinnacle Research Group
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.

stone removal
endoscopy
nephrolithotomy
antibiotics
antibiotic therapy
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

viral test
active treatment
acute respiratory syndrome (sars)
hematopoietic and lymphoid cell neoplasm
solid tumor
University of Texas Health Science Center at San Antonio
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +575 other locations